Caudal blockade is frequently used in pediatric anesthesia as it is considered safe and offers sufficient pain relief during ...

Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) ("Virpax" or the "Company"), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central ...

Seventy-one University of Kentucky students will present their research at the National Conference on Undergraduate Research ...

Virpax Pharmaceuticals (VRPX) announced positive results from a beagle dog dose range finding study. Probudur is the company’s long-acting ...

DURECT Corporation (Nasdaq: DRRX), a late-stage biopharmaceutical company pioneering the development of epigenetic therapies ...

SAN DIEGO — Prophylactic measures such as vancomycin, povidone-iodine and saline irrigation yielded similar rates of periprosthetic joint infection and wound complications at 3 months for high ...

Virpax Pharmaceuticals, Inc. ("Virpax" or the "Company") a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous system (CNS) ...

CUPERTINO, Calif., March 19, 2025 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX), a late-stage biopharmaceutical company pioneering the development of epigenetic therapies that target ...

Pacira already sells post-surgical painkiller Exparel (bupivacaine liposome injectable suspension), which accounted for the bulk of its $136 million sales in the second quarter. The deal also adds ...

PARSIPPANY, N.J., March 14, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the ...